Authors:
COPOLOV DL
MACKINNON AJ
THOMAS R
SIMS EF
SEAL ML
Citation: Dl. Copolov et al., THE RELATIONSHIP BETWEEN THE PHENOMENOLOGY OF AUDITORY HALLUCINATIONSAND THE PERCEIVED EFFICACY OF COPING MECHANISMS, Schizophrenia research, 29(1-2), 1998, pp. 38-38
Authors:
COPOLOV DL
DEAN B
VELAKOULIS D
NAYLOR L
OPESKIN K
PAVEY G
HILL C
KEKS N
YUNG A
MCGORRY P
SEAL ML
PANTELIS C
Citation: Dl. Copolov et al., HIPPOCAMPAL ABNORMALITIES IN SCHIZOPHRENIA - FINDINGS FROM NEUROTRANSMITTER AND STRUCTURAL IMAGING STUDIES, Schizophrenia research, 29(1-2), 1998, pp. 82-83
Authors:
FARNBACHPRALONG D
BRADBURY R
COPOLOV DL
DEAN B
Citation: D. Farnbachpralong et al., GABA(A) RECEPTORS ARE NOT ALTERED IN THE AUDITORY-LINGUISTIC ASSOCIATION CORTEX OF SUBJECTS WITH SCHIZOPHRENIA BUT ARE MARKEDLY DECREASED IN THE AUDITORY-CORTEX OF RATS TREATED WITH CLOZAPINE AND OLANZAPINE, Schizophrenia research, 29(1-2), 1998, pp. 97-97
Authors:
COPOLOV DL
BELL WR
BENSON WJ
KEKS NA
STRAZZERI DC
JOHNSON GF
Citation: Dl. Copolov et al., CLOZAPINE TREATMENT IN AUSTRALIA - A REVIEW OF HEMATOLOGICAL MONITORING, Medical journal of Australia, 168(10), 1998, pp. 495-497
Authors:
ROBERTS SB
HILL CA
DEAN B
KEKS NA
OPESKIN K
COPOLOV DL
Citation: Sb. Roberts et al., CONFIRMATION OF THE DIAGNOSIS OF SCHIZOPHRENIA AFTER DEATH USING DSM-IV - A VICTORIAN EXPERIENCE, Australian and New Zealand Journal of Psychiatry, 32(1), 1998, pp. 73-76
Authors:
COPOLOV DL
EGAN GF
WONG MTH
MARUFF P
TOCHONDANGUY HJ
CHAN JG
WAITE M
Citation: Dl. Copolov et al., PET CORRELATIONAL STUDIES OF AUDITORY-STIMULATION AND AUDITORY HALLUCINATIONS IN SCHIZOPHRENIA-PATIENTS, Schizophrenia research, 24(1-2), 1997, pp. 164-164
Authors:
DEAN B
CROOK JM
OPESKIN K
HILL C
KEKS N
COPOLOV DL
Citation: B. Dean et al., THE DENSITY OF MUSCARINIC M(1) RECEPTORS IS DECREASED IN THE CAUDATE-PUTAMEN OF SUBJECTS WITH SCHIZOPHRENIA, Molecular psychiatry, 1(1), 1996, pp. 54-58
Citation: B. Dean et al., PLATELET [H-3]DOPAMINE UPTAKE IS DIFFERENTIALLY AFFECTED BY NEUROLEPTIC DRUG-TREATMENT IN SCHIZOPHRENIA AND SCHIZOPHRENIFORM DISORDER, Progress in neuro-psychopharmacology & biological psychiatry, 20(1), 1996, pp. 45-55
Citation: S. Sundram et al., TYPICAL AND ATYPICAL NEUROLEPTIC DRUGS DECREASE PLATELET H-3 DOPAMINEUPTAKE IN THE RAT, Psychiatry research, 62(3), 1996, pp. 259-263
Citation: Dc. Wan et al., TREATMENT WITH HALOPERIDOL OR CLOZAPINE CAUSES CHANGES IN DOPAMINE-RECEPTORS BUT NOT ADENYLATE-CYCLASE OR PROTEIN-KINASE-C IN THE RAT FOREBRAIN, Life sciences, 59(23), 1996, pp. 2001-2008
Citation: Dm. Carter et al., PATIENTS STRATEGIES FOR COPING WITH AUDITORY HALLUCINATIONS, The Journal of nervous and mental disease, 184(3), 1996, pp. 159-164
Citation: Zy. Yang et al., ASCORBIC-ACID AUGMENTS THE ADENYLYL CYCLASE-CAMP SYSTEM MEDIATED POMCMESSENGER-RNA EXPRESSION AND BETA-ENDORPHIN SECRETION FROM HYPOTHALAMIC NEURONS IN CULTURE, Brain research, 706(2), 1996, pp. 243-248
Authors:
CARTER DM
MACKINNON A
HOWARD S
ZEEGERS T
COPOLOV DL
Citation: Dm. Carter et al., THE DEVELOPMENT AND RELIABILITY OF THE MENTAL-HEALTH RESEARCH-INSTITUTE UNUSUAL PERCEPTIONS SCHEDULE (MUPS) - AN INSTRUMENT TO RECORD AUDITORY HALLUCINATORY EXPERIENCE, Schizophrenia research, 16(2), 1995, pp. 157-165
Authors:
KEKS NA
HILL C
DEAN B
OPESKIN K
COPOLOV DL
Citation: Na. Keks et al., DIAGNOSIS AS A CONFOUNDING VARIABLE FOR POSTMORTEM BRAIN STUDIES IN SCHIZOPHRENIA, Schizophrenia research, 15(1-2), 1995, pp. 29-29
Citation: Bm. Matheson et al., BASAL AND HALOPERIDOL - STIMULATED PROLACTIN IN FIRST-DEGREE RELATIVES OF SCHIZOPHRENIC PROBANDS, Schizophrenia research, 15(1-2), 1995, pp. 61-61
Authors:
DEAN B
HAYES W
OPESKIN K
NAYLOR L
PAVEY G
HILL C
KEKS N
COPOLOV DL
Citation: B. Dean et al., SEROTONIN(2) RECEPTORS AND THE SEROTONIN TRANSPORTER IN THE SCHIZOPHRENIC BRAIN, Behavioural brain research, 73(1-2), 1995, pp. 169-175
Authors:
DEAN B
OPESKIN K
PAVEY G
NAYLOR L
HILL C
KEKS N
COPOLOV DL
Citation: B. Dean et al., [H-3] PAROXETINE BINDING IS ALTERED IN THE HIPPOCAMPUS BUT NOT THE FRONTAL-CORTEX OR CAUDATE-NUCLEUS FROM SUBJECTS WITH SCHIZOPHRENIA, Journal of neurochemistry, 64(3), 1995, pp. 1197-1202
Citation: D. Lee et al., GLUCOCORTICOIDS INHIBIT D-1B, BUT NOT D-2, RECEPTOR-MEDIATED EFFECTS ON HYPOTHALAMIC ATRIAL-NATRIURETIC-FACTOR NEURONS, Endocrinology, 136(12), 1995, pp. 5570-5576
Citation: Zy. Yang et al., GLUTAMATE ENHANCES THE ADENYLYL CYCLASE-CAMP SYSTEM-INDUCED BETA-ENDORPHIN SECRETION AND POMC MESSENGER-RNA EXPRESSION IN RAT HYPOTHALAMIC NEURONS IN CULTURE - NMDA RECEPTOR-MEDIATED MODULATION, Brain research, 692(1-2), 1995, pp. 129-136
Authors:
KEKS NA
COPOLOV DL
MCKENZIE DP
KULKARNI J
HILL C
HOPE JD
SINGH BS
Citation: Na. Keks et al., BASAL AND HALOPERIDOL-STIMULATED PROLACTIN AND SYMPTOMS OF NONAFFECTIVE AND AFFECTIVE PSYCHOSES IN NEUROLEPTIC-FREE MEN, Biological psychiatry, 37(4), 1995, pp. 229-234
Citation: D. Lee et al., D-2 RECEPTORS MEDIATE DOPAMINE SUPPRESSION OF IRANF RELEASE AND PRO-ANF MESSENGER-RNA EXPRESSION OF RAT HYPOTHALAMIC NEURONS IN CULTURE, Molecular and cellular neurosciences, 5(6), 1994, pp. 523-529
Citation: S. Sundram et al., THE EFFECT OF NEUROLEPTIC TREATMENT ON DOPAMINE UPTAKE BY PLATELETS FROM SUBJECTS WITH PSYCHOSIS, Schizophrenia research, 11(2), 1994, pp. 113-114